Drug
Acdn 01
Acdn 01: highest development phase Phase 1/2, developed by Ascidian Therapeutics, Inc. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Ascidian Therapeutics, Inc
Trials
| Drug | Phase | Indication |
|---|---|---|
| ACDN-01 NCT06467344 | Phase 1/2 | Stargardt Disease |
Latest
No recent events.
Follow Acdn 01 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.